Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cirtran (CIRX) Liabilities and Shareholders Equity (2017 - 2025)

Cirtran filings provide 14 years of Liabilities and Shareholders Equity readings, the most recent being $2.5 million for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 64.07% to $2.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.8 million, a 1.18% decrease, with the full-year FY2025 number at $2.5 million, up 64.07% from a year prior.
  • Liabilities and Shareholders Equity hit $2.5 million in Q4 2025 for Cirtran, up from $1.9 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $2.5 million in Q4 2025 to a low of $1.5 million in Q1 2021.
  • Median Liabilities and Shareholders Equity over the past 5 years was $1.8 million (2022), compared with a mean of $1.8 million.
  • Biggest five-year swings in Liabilities and Shareholders Equity: soared 140.64% in 2021 and later dropped 28.13% in 2025.
  • Cirtran's Liabilities and Shareholders Equity stood at $1.5 million in 2021, then skyrocketed by 36.57% to $2.0 million in 2022, then fell by 7.5% to $1.8 million in 2023, then fell by 17.11% to $1.5 million in 2024, then surged by 64.07% to $2.5 million in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $2.5 million (Q4 2025), $1.9 million (Q3 2025), and $1.6 million (Q2 2025) per Business Quant data.